Skip to main navigation

>> Site Menu

Our Company
Our Science
- ABCD Platform
- Scientific Presentations
Focus Areas
Our Pipeline
Our Culture
- Join the Team
INVESTORS & MEDIA

New Human Ocular Durability Data

New ABCD Formulation

New Pivotal Trial Designs

Learn more at our
Investor R&D Day

Kodiak Sciences

>> Site Menu

Our Company
Our Science
Focus Areas
Our Pipeline
Our Culture
- Join the Team
INVESTORS & MEDIA

News Releases

> News - Sub Nav

Press Releases

News Releases

Year

March 28, 2024

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Additional Formats

PDF Version

March 26, 2024

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

Additional Formats

PDF Version

January 30, 2024

Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting

Additional Formats

PDF Version

January 4, 2024

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Additional Formats

PDF Version

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 14 of 14

Disclaimer

Some of the statements on this site are forward-looking. Such statements are inherently subject to known as well as unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements of Kodiak Sciences to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements speak only as of the date they are posted to this website (unless an earlier date is indicated). Kodiak Sciences does not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Kodiak’s drug candidates are investigational compounds in development and have not received regulatory approval in any country.

KODIAK SCIENCES INC.

1200 Page Mill Road
Palo Alto, CA 94304
United States of America

Kodiak Sciences GMBH
Dammstrasse 19
6300 ZUG
Switzerland

info@kodiak.com

Kodiak Sciences Valais GMBH
Rottenstrasse 5
3930 VISP
Switzerland

LinkedIn Twitter